Vakaramoko Diaby to Budgets
This is a "connection" page, showing publications Vakaramoko Diaby has written about Budgets.
Connection Strength
2.465
-
Diaby V, Pandey S, Sanogo V, Dhayan Almutairi R, Kanoria Y, Nag SS. Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with schizophrenia in the United States. J Manag Care Spec Pharm. 2025 Jan; 31(1):53-59.
Score: 0.904
-
Diaby V, Pandey S, Sanogo V, Almutairi RD, Kanoria Y, Nag SS. Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with bipolar I disorder in the United States. J Manag Care Spec Pharm. 2025 Jan; 31(1):60-67.
Score: 0.904
-
Diaby V, Adunlin G, Montero AJ. Re: Xie J, Diener M, De G, et al. Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in the United States. J Med Econ 2014;16(2):278-88. J Med Econ. 2014 Apr; 17(4):248-9.
Score: 0.426
-
Sanogo V, Saud Almutairi RD, Diaby V. Budget impact of lecanemab for medicare beneficiaries with early Alzheimer's disease in the United States: a subgroup analysis. Expert Rev Pharmacoecon Outcomes Res. 2025 Dec; 25(10):1421-1426.
Score: 0.232